You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Exenatide

Showing 376 - 400 of 425
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes Trial in Seoul (YH14617, Placebo)

Completed
  • Diabetes Mellitus
  • Seoul, Korea, Republic of
    Yuhan
Feb 16, 2015

Healthy Trial in Seoul (Sitagliptin)

Unknown status
  • Healthy
  • Seoul, Korea, Republic of
    Kyung Hee University Hospital
Apr 1, 2015

Diabetes, Non-Insulin-Dependent Trial in United States (AC2993, Placebo)

Completed
  • Diabetes Mellitus, Non-Insulin-Dependent
  • Anniston, Alabama
  • +125 more
Feb 23, 2015

Diabetes, Type 2 Trial in United States (AC2993, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +128 more
Feb 23, 2015

Type 1 Diabetes Trial in Williamsville (Liraglutide, Placebo)

Completed
Has Results
  • Type 1 Diabetes
  • Williamsville, New York
    Diabetes-Endocrinology Center of Western NY
Mar 2, 2015

Diabetes, Non-Insulin-Dependent Trial in United States (AC2993, Placebo)

Completed
  • Diabetes Mellitus, Non-Insulin-Dependent
  • Anniston, Alabama
  • +99 more
Feb 23, 2015

Impaired Glucose Tolerance Trial in St. Louis Park, St. Paul (Exenatide, Metformin)

Completed
Has Results
  • Impaired Glucose Tolerance
  • St. Louis Park, Minnesota
  • +1 more
Sep 5, 2013

Hypothalamic Obesity, Diabetes Trial in Shanghai (Exenatide)

Unknown status
  • Hypothalamic Obesity
  • Diabetes Mellitus
  • Exenatide
  • Shanghai, Shanghai, China
    Department of Endocrinology and Metabolism
Oct 20, 2013

Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients

Completed
  • Hyperinsulinism
  • +2 more
  • 111In-exendin-4 imaging
  • Basel, Basel-Stadt, Switzerland
    University Hospital Basel, Institute of Nuclear Medicine
Jan 8, 2015

Glucagon-like Peptide (GLP) Utilization and Safety

Completed
  • Diabetes Mellitus, Type 2
  • The GLP-1 receptor agonist users
  • +2 more
  • (no location specified)
Jul 31, 2014

Diabetes, Non-Insulin-Dependent Trial in United States (Placebo 0.01 mL, Placebo 0.02 mL, Placebo 0.03 mL)

Completed
  • Diabetes Mellitus, Non-Insulin-Dependent
  • Placebo 0.01 mL
  • +7 more
  • Birmingham, Alabama
  • +32 more
Feb 19, 2015

Type 2 Diabetes Trial in Canada, United States (AC2993)

Completed
  • Type 2 Diabetes Mellitus
  • Anniston, Alabama
  • +225 more
Feb 23, 2015

Type 2 Diabetes Trial in Seoul (SR Exenatide (PT302), Placebo)

Completed
  • Type 2 Diabetes Mellitus
  • SR Exenatide (PT302)
  • Placebo
  • Seoul, Korea, Republic of
    Clinical Trials Center, Seoul National University Hospital
Jul 18, 2013

Type 2 Diabetes Trial in Taipei (Exenatide, Humulin-N)

Unknown status
  • Type 2 Diabetes
  • Taipei, Taiwan
    Taipei Veterans General Hospital
Jun 26, 2013

Type 2 Diabetes Trial in Taoyuan (Exenatide, Normal saline)

Completed
  • Type 2 Diabetes Mellitus
  • Exenatide
  • Normal saline
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Jul 28, 2013

Diabetes Trial in Seoul (SR-exenatide)

Completed
  • Diabetes Mellitus
  • Seoul, Korea, Republic of
    Clinical Trial center, Clinical Research institute, Seoul Nation
Aug 12, 2013

Diabetes, Type 2, Newly Diagnosed Trial in China (exenatide injection, Mixed Protamine Zinc Recombinant Human Insulin Lispro

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Newly Diagnosed
  • exenatide injection
  • +2 more
  • Beijing, Beijing, China
  • +24 more
Jun 11, 2013

Type 2 Diabetes Trial in Washington DC, Rochester, Portland (exenatide, )

Completed
Has Results
  • Type 2 Diabetes
  • exenatide
  • placebo
  • Washington DC, District of Columbia
  • +2 more
Feb 4, 2013

Type 2 Diabetes Trial in Miami Gardens, Cincinnati, San Antonio (ITCA 650 (exenatide in DUROS))

Completed
Has Results
  • Type 2 Diabetes
  • ITCA 650 (exenatide in DUROS)
  • Miami Gardens, Florida
  • +2 more
Apr 5, 2013

Diabetes Trial in California (HM11260C, Placebo, Victoza)

Unknown status
  • Diabetes Mellitus
  • California, California
    Hanmi
Feb 7, 2014

Type 2 Diabetes Trial in Buffalo (exenatide 5 mcg, exenatide 10 mcg, )

Completed
  • Type 2 Diabetes
  • exenatide 5 mcg
  • +2 more
  • Buffalo, New York
    Millard Fillmore Gates Hospital
Dec 14, 2012

Obesity, Insulin Resistance, Impaired Glucose Tolerance Trial (Exenatide)

Withdrawn
  • Obesity
  • +3 more
  • Exenatide
  • (no location specified)
Dec 10, 2012

Healthy Trial in Køge (1,5 nmol/kg,GLP-1 sc injection, 1,5 nmol/kg GLP-1 9-36amide, sc injection, Exendin-4 ;10 ug,sc injection)

Unknown status
  • Healthy
  • 1,5 nmol/kg,GLP-1 sc injection
  • +3 more
  • Køge, State..., Denmark
    Køge Hospital
Nov 19, 2013

Obesity, Morbid Trial in Minneapolis (Exenatide)

Completed
Has Results
  • Obesity, Morbid
  • Exenatide
  • Minneapolis, Minnesota
    University of Minnesota
Oct 22, 2012

Type 2 Diabetes Trial in Beijing (PEX168)

Completed
  • Type 2 Diabetes
  • Beijing, Beijing, China
    Beijing tongren hospital
Oct 30, 2013